The complex relationship between metabolic syndrome and sweeteners
| Autor: | Andrea R Gómez-Fernández, Arlette Santacruz, Daniel A. Jacobo-Velázquez |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
030309 nutrition & dietetics
Human metabolism Type 2 diabetes Disease Gut flora Bioinformatics Receptors G-Protein-Coupled 03 medical and health sciences 0404 agricultural biotechnology medicine Humans Obesity Metabolic Syndrome 0303 health sciences biology business.industry digestive oral and skin physiology food and beverages Sweet taste 04 agricultural and veterinary sciences biology.organism_classification medicine.disease 040401 food science Gastrointestinal Microbiome Diabetes Mellitus Type 2 Sweetening Agents Dysbiosis Metabolic syndrome business Food Science |
| Zdroj: | Journal of Food Science. 86:1511-1531 |
| ISSN: | 1750-3841 0022-1147 |
| DOI: | 10.1111/1750-3841.15709 |
| Popis: | Metabolic syndrome is a multifactorial disorder originating from central obesity through a high caloric intake and a sedentary lifestyle. Metabolic syndrome increases the risk of type 2 diabetes (T2D) disease, converting it to one of the costliest chronic diseases, which reduces life quality. A strategy proposed by the food industry to reduce this problem is the generation of low-caloric products using sweeteners, which are compounds that can substitute sucrose, given their sweet taste. For many years, it was assumed that sweeteners did not have a relevant interaction in metabolism. However, recent studies have demonstrated that sweeteners interact either with metabolism or with gut microbiota, in which sweet-taste receptors play an essential role. This review presents an overview of the industrial application of most commonly consumed sweeteners. In addition, the interaction of sweeteners within the body, including their absorption, distribution, metabolism, gut microbiota metabolism, and excretion is also reviewed. Furthermore, the complex relationship between metabolic syndrome and sweeteners is also discussed, presenting results from in vivo and clinical trials. Findings from this review indicate that, in order to formulate sugar-free or noncaloric food products for the metabolic syndrome market, several factors need to be considered, including the dose, proportions, human metabolism, and interaction of sweeteners with gut microbiota and sweet-taste receptors. More clinical studies, including the metabolic syndrome, are needed to better understand the interaction of sweeteners with the human body, as well as their possible effect on the generation of dysbiosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text